Serious Adverse Events of Special Interest Following mRNA Vaccination in Randomized Trials
mathewaldred.substack.com
Serious Adverse Events of Special Interest Following mRNA Vaccination in Randomized Trials
New paper by Professor Doshi et al: The excess risk of serious adverse events of special interest surpassed the risk reduction for COVID-19 hospitalization relative to the placebo group